UNIPHYLLIN

This brand name is authorized in Cyprus, Ireland, Malta, United Kingdom

Active ingredients

The drug UNIPHYLLIN contains one active pharmaceutical ingredient (API):

1 Theophylline UNII C137DTR5RG - THEOPHYLLINE

Theophylline is a bronchodilator. In addition it affects the function of a number of cells involved in the inflammatory processes associated with asthma and chronic obstructive airways disease. Theophylline stimulates the myocardium and produces a diminution of venous pressure in congestive heart failure leading to marked increase in cardiac output. Read about Theophylline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
UNIPHYLLIN CONTINUS Prolonged release tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03DA04	Theophylline	R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DA Xanthines
Discover more medicines within R03DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 23279, 28920, 28926
Country: IE	Health Products Regulatory Authority	Identifier(s): 48747, 49026, 54852
Country: MT	Medicines Authority	Identifier(s): AA565/65501